Prevention Genetics Logo
Test Code 15423
New York approved

Stroke, Cerebral Hemorrhage, Hemiplegia, and Migraine Panel

160 genes

2 - 3 weeks (7 - 16 days STAT)

Who is this test for?
  • Individuals with relevant features who have a clinical or suspected diagnosis of stroke, cerebral hemorrhage, hemiplegia, or migraine
  • Individuals with a family history of stroke, cerebral hemorrhage, or hemiplegic migraine
Method
NGS with CNV (Exome or Genome Platform)
Specimen(s)

Exome Platform: Blood, DNA, Buccal, Saliva, Tissue

Genome Platform: Blood, DNA

Order Options

Platform
Test type
OTHER OPTIONS
for pricing.

Explore related tests

Questions? We can help.

Getting support has never been easier. Connect with our team for assistance with anything from test selection to interpreting results. Use the live chat button or visit our Contact us page.